This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noiseux, N. Articles by Sirois, M. G. Search for Related Content PubMed PubMed Citation Articles by Noiseux, N. Articles by Sirois, M. G. Related Collections Restenosis Restenosis Carotid Stenosis Gene therapy

(Circulation. 2000;102:1330.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Bolus Endovascular PDGFR-ß Antisense Treatment Suppressed Intimal Hyperplasia in a Rat Carotid Injury Model

Nicolas Noiseux, MD, MSc; Caroline H. Boucher, BSc; Raymond Cartier, MD; Martin G. Sirois, PhD

From the Montreal Heart Institute and Department of Pharmacology, University of Montreal, Montreal, Québec, Canada.

Correspondence to Martin G. Sirois, PhD, Montreal Heart Institute, 5000 Belanger St, Montreal, Québec, Canada H1T 1C8. E-mail mgsirois{at}icm.umontreal.ca

Background—Intimal thickening in accelerated arteriopathies relies on the migration of medial vascular smooth muscle cells (VSMCs) and their proliferation within the neointima. Activation of platelet-derived growth factor receptor-ß (PDGFR-ß) expressed in injured VSMCs is responsible for the migration of medial VSMCs to the intima. In the present study, we wanted to assess whether a single local endovascular delivery of antisense PDGFR-ß in injured rat carotid arteries would be sufficient to prevent intimal hyperplasia and how it might contribute to the vascular healing process.

Methods and Results—A bolus of antisense PDGFR-ß delivered into injured rat carotid arteries reduced PDGFR-ß protein overexpression by >90% from day 3 to 28 after injury. At day 28 after injury, compared with injured untreated carotids, treatment with antisense PDGFR-ß reduced intimal hyperplasia by 58% and medial VSMC migration by 49% and improved vascular reendothelialization by 100% and vascular reactivity (EC₅₀) to acetylcholine by 5-fold.

Conclusions—A single-bolus luminal delivery of antisense PDGFR-ß to injured rat carotids reduced intimal hyperplasia, improved the reendothelialization process, and led to the recovery of endothelium-dependent regulation of vascular tone.

Key Words: gene therapy • angioplasty • growth substances • restenosis

This article has been cited by other articles:

				D. Zhuang, Q. Pu, B. Ceacareanu, Y. Chang, M. Dixit, and A. Hassid Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H163 - H173. [Abstract] [Full Text] [PDF]

				K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2203 - H2209. [Abstract] [Full Text] [PDF]

				C. Bartels, A. Erasmi, F. Sayk, R. Eggers, A. Dendorfer, T. Feyerabend, W. Eichler, and Hans.-H. Sievers Prophylactic gamma radiation of unaffected vein grafts failed to prevent vein graft disease in a chronic hypercholesterolemic porcine model Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 92 - 97. [Abstract] [Full Text] [PDF]